Investeringsoversigt
728 investments
| Titel Sort descending | Periode | Program | |
|---|---|---|---|
| FuelVision UI/UX | 2022 - 2023 | Innobooster
|
|
|
FuelVision UI/UX
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
32 Invested
710.400 Budget
2.2 mill. Partners
FuelVision People
Read more about the project
| |||
| Fuldautomatisk kontrol- og vejesystem | 2022 - 2024 | Innobooster
|
|
|
Fuldautomatisk kontrol- og vejesystem
Period
2022 - 2024
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
650.126 Budget
1.9 mill. Partners
Ceetec People
Read more about the project
| |||
| Fundamental understanding of drug delivery from transdermal patches | 2022 - 2025 | Industrial Researcher
|
|
|
Fundamental understanding of drug delivery from transdermal patches
Period
2022 - 2025
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
71.51 Invested
1.1 mill. Budget
1.5 mill. Partners
Technical University of Denmark, Glysious ApS People
Glysious ApS
Read more about the project
| |||
| Færdigudvikling af metanolmotorer til marinesektoren og udvikling af test-faciliteter | 2022 - 2022 | Innobooster
|
|
|
Færdigudvikling af metanolmotorer til marinesektoren og udvikling af test-faciliteter
Period
2022 - 2022
Region
Region Midtjylland Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
498.750 Budget
1.4 mill. Partners
Nordhavn Power Solutions A/S People
Nordhavn A/S
Read more about the project
| |||
| Færdigudvikling af performancemålingsværktøj med AI Performance Score Model | 2022 - 2023 | Innobooster
|
|
|
Færdigudvikling af performancemålingsværktøj med AI Performance Score Model
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
496.100 Budget
1.4 mill. Partners
Frontliners ApS People
Read more about the project
| |||
| GEAbetes Innobooster 2,0 - Obesity diabetes II treatment | 2022 - 2024 | Innobooster
|
|
|
GEAbetes Innobooster 2,0 - Obesity diabetes II treatment
Period
2022 - 2024
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
824.572 Budget
2.4 mill. Partners
GEAbetes ApS People
Read more about the project
| |||
| Genansøgning - Del 2 - Modulbaseret backend til verdens mest innovative kaffeløsning | 2022 - 2022 | Innobooster
|
|
|
Genansøgning - Del 2 - Modulbaseret backend til verdens mest innovative kaffeløsning
Period
2022 - 2022
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
402.413 Budget
1.1 mill. Partners
Cafeu Danmark SpS People
CAFÉU DENMARK ApS
Read more about the project
| |||
| Genanvende restaffald fra kraftvarmeværker og røgrensning i skibe som alternativ til deponi | 2022 - 2023 | Innobooster
|
|
|
Genanvende restaffald fra kraftvarmeværker og røgrensning i skibe som alternativ til deponi
Period
2022 - 2023
Region
Region Syddanmark Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
642.250 Budget
1.8 mill. Partners
Agro Trade A/S People
AGRO TRADE ApS
Read more about the project
| |||
| Genbrugsmursten | 2022 - 2022 | Innobooster
|
|
|
Genbrugsmursten
Period
2022 - 2022
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
214.200 Budget
612.000 Partners
Industriservice People
INDUSTRISERVICE V/KLAUS SAABY HANSEN
Read more about the project
| |||
| Genbrugsplast Plader | 2022 - 2023 | Innofounder
|
|
|
Genbrugsplast Plader
Period
2022 - 2023
Region
Region Hovedstaden Program
Innofounder Area
Ikke defineret Investment
Percentage
100 Invested
760.000 Budget
760.000 Partners
Plastic Projects ApS People
Plastic Projects ApS
Read more about the project
| |||
| Generating a metabolically mature human skeletal muscle in vitro model using 3D bioprinting, innervation and actuation | 2022 - 2025 | Industrial Researcher
|
|
|
Generating a metabolically mature human skeletal muscle in vitro model using 3D bioprinting, innervation and actuation
Period
2022 - 2025
Region
Region Hovedstaden Program
Erhvervsforsker Area
Ikke defineret Investment
Percentage
46.19 Invested
1.2 mill. Budget
2.7 mill. Partners
Technical University of Denmark, Novo Nordisk A/S - E1 People
Novo Nordisk A/S - E1
Read more about the project
| |||
| Generation of novel diabetes therapeutics II: proceedings through development | 2022 - 2023 | Innobooster
|
|
|
Generation of novel diabetes therapeutics II: proceedings through development
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
1.13 Invested
153.722 Budget
13.6 mill. Partners
Embark Biotech ApS People
Read more about the project
| |||
| gimio - Del, gem eller køb dine ønsker blot ved ét billede. | 2022 - 2023 | Innobooster
|
|
|
gimio - Del, gem eller køb dine ønsker blot ved ét billede.
Period
2022 - 2023
Region
Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
494.375 Budget
1.4 mill. Partners
Scan a Wish ApS People
Read more about the project
| |||
| GLYCOSTAT Glycostat market entry supported by clinical study involving seriously ill patients | 2022 - 2023 | Grand Solutions
|
|
|
GLYCOSTAT Glycostat market entry supported by clinical study involving seriously ill patients
Period
2022 - 2023
Region
Region Syddanmark Program
Grand Solutions Area
Ikke defineret Investment
Percentage
74.97 Invested
5.0 mill. Budget
6.7 mill. Partners
FLOWSION A/S, Aalborg Universitetshospital People
FLOWSION A/S
Read more about the project
| |||
| gMendel®Test - A novel diagnostic tool for detection and medical interpretation of rare/genetic disorders | 2022 - 2023 | Innobooster
|
|
|
gMendel®Test - A novel diagnostic tool for detection and medical interpretation of rare/genetic disorders
Period
2022 - 2023
Region
Region Hovedstaden Program
Innobooster Area
Ikke defineret Investment
Percentage
35 Invested
1.5 mill. Budget
4.2 mill. Partners
gMendel ApS People
gMendel ApS
Read more about the project
| |||